Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18693)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 14, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kubo N, Araki K, Kuwano H, Shirabe K. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol 2016; 22(30): 6841-6850 [PMID: 27570421 DOI: 10.3748/wjg.v22.i30.6841] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i30/6841.htm |
| Number | Citing Articles |
| 1 |
Chen Han, Yongjie Jiang, Zhaoxia Wang, Hengxiao Wang. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar. International Immunopharmacology 2019; 73: 10 doi: 10.1016/j.intimp.2019.04.057
|
| 2 |
Xin Jin, Haida Shi, Zhi Li, Huixing Li, Huanxian Ma, Xianjie Shi, Mingjun Zheng. Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2717056
|
| 3 |
Difeng Li, Xin Zhang, Lili Jiang. Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1000807
|
| 4 |
Leonard Kaps, Detlef Schuppan. Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells 2020; 9(9): 2027 doi: 10.3390/cells9092027
|
| 5 |
Jun Zhang, Yuliang Pan, Long Jin, Huiyun Yang, Peiguo Cao. Exosomal‐miR‐522‐3p derived from cancer‐associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer. Journal of Gastroenterology and Hepatology 2024; 39(1): 107 doi: 10.1111/jgh.16345
|
| 6 |
Rui Feng, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Shuichi Iwahashi, Yu Saito, Mitsuo Shimada. Nab‐paclitaxel interrupts cancer‐stromal interaction through C‐X‐C motif chemokine 10‐mediated interleukin‐6 downregulation in vitro. Cancer Science 2018; 109(8): 2509 doi: 10.1111/cas.13694
|
| 7 |
Jian Guo, Huating Zeng, Yan Chen. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration. Molecular Pharmaceutics 2020; 17(4): 1028 doi: 10.1021/acs.molpharmaceut.0c00014
|
| 8 |
Yi-Chang Wang, Yu-Syuan Wu, Chia-Yang Hung, Shao-An Wang, Ming-Jer Young, Tsung-I Hsu, Jan-Jong Hung. USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy. Nature Communications 2018; 9(1) doi: 10.1038/s41467-018-06178-1
|
| 9 |
Shaoshi Zhang, Wendi Bacon, Maikel P. Peppelenbosch, Folkert van Kemenade, Andrew Peter Stubbs. Deciphering Tumour Microenvironment of Liver Cancer through Deconvolution of Bulk RNA-Seq Data with Single-Cell Atlas. Cancers 2022; 15(1): 153 doi: 10.3390/cancers15010153
|
| 10 |
Hyungjin Rhee, Hye-Young Kim, Ji-Hye Choi, Hyun Goo Woo, Jeong Eun Yoo, Ji Hae Nahm, Jin-Sub Choi, Young Nyun Park. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis. Cancer Research 2018; 78(7): 1619 doi: 10.1158/0008-5472.CAN-17-0988
|
| 11 |
Hidenori Shiraha, Masaya Iwamuro, Hiroyuki Okada. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1234: 43 doi: 10.1007/978-3-030-37184-5_4
|
| 12 |
Qiang Yuan, Yi Chu, Xiaoyu Li, Yunshu Shi, Yingying Chen, Jimin Zhao, Jing Lu, Kangdong Liu, Yaping Guo. CAFrgDB: a database for cancer-associated fibroblasts related genes and their functions in cancer. Cancer Gene Therapy 2023; 30(6): 917 doi: 10.1038/s41417-023-00603-4
|
| 13 |
Siming Gong, Changwu Wu, Yingjuan Duan, Juyu Tang, Panfeng Wu. A Comprehensive Pan-Cancer Analysis for Pituitary Tumor-Transforming Gene 1. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.843579
|
| 14 |
Zhong-Yang Jiang, Xi-Mei Ma, Xiao-Hui Luan, Zhen-Yu Liuyang, Yi-Yang Hong, Yuan Dai, Qing-Hua Dong, Guan-Yu Wang. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells. World Journal of Gastroenterology 2023; 29(23): 3606-3621 doi: 10.3748/wjg.v29.i23.3606
Abstract(373) |
Core Tip(322) |
Full Article(HTML)(1512)
|
Full Article with Cover (PDF)-34735K(49)
|
Full Article (Word)-9640K(37)
|
Audio-476K(2)
|
Peer-Review Report-230K(23)
|
Answering Reviewers-103K(25)
|
Supplementary Material-33K(31)
|
Full Article (PDF)-28825K(135)
|
Full Article (XML)-145K(31)
|
Times Cited (0)
|
Total Visits (4132)
|
Open
|
| 15 |
Massimiliano Berretta, Luca Rinaldi, Fabrizio Di Benedetto, Arben Lleshi, Vallì De Re, Gaetano Facchini, Paolo De Paoli, Raffaele Di Francia. Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00428
|
| 16 |
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(7): 1745 doi: 10.3390/ijms20071745
|
| 17 |
Gurbet Celik-Turgut, Nazmiye Olmez, Tugba Koc, Ozden Ozgun-Acar, Asli Semiz, Yavuz Dodurga, Naciye Lale Satiroglu-Tufan, Alaattin Sen. Role of AHR, NF-kB and CYP1A1 crosstalk with the X protein of Hepatitis B virus in hepatocellular carcinoma cells. Gene 2023; 853: 147099 doi: 10.1016/j.gene.2022.147099
|
| 18 |
Yiming Shen, Zhengyu Wei, Chongchang Zhou, Jiangping Song, Jianing Wang, Jiada Wang, Linrong Wu, Shenzhe Fang, Zhisen Shen. Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer. Journal of Clinical Laboratory Analysis 2022; 36(9) doi: 10.1002/jcla.24600
|
| 19 |
Xingcheng Xiong, Juanli Xi, Qian Liu, Cixiao Wang, Zeyou Jiang, Su‐Yang Yue, Lei Shi, Yuping Rong, Carmen Berasain. Co‐expression of IL‐7 and PH20 promote anti‐GPC3 CAR‐T tumour suppressor activity in vivo and in vitro. Liver International 2021; 41(5): 1033 doi: 10.1111/liv.14771
|
| 20 |
Jacek R. Wilczyński. Interaction of Immune and Cancer Cells. Experientia Supplementum 2022; 113: 219 doi: 10.1007/978-3-030-91311-3_8
|
| 21 |
Lushan Peng, Dan Wang, Yingying Han, Tao Huang, Xiaoyun He, Junpu Wang, Chunlin Ou. Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.795372
|
| 22 |
Yang-Hsiang Lin, Meng-Han Wu, Chau-Ting Yeh, Kwang-Huei Lin. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication. International Journal of Molecular Sciences 2018; 19(12): 3742 doi: 10.3390/ijms19123742
|
| 23 |
Hamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, Maryam Bakhtiyari, Abdullatif Akbari, Mohsen Nabi-Afjadi, Razieh Forghaniesfidvajani, Nima Rezaei. The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. Cell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00951-y
|
| 24 |
Longfei Xiao, Zihui Wang, Ning Lu, Huawei Wei, Jian Kang, Mengyi Yuan, Xihui Sheng, Xiaolong Qi, Kai Xing, Yong Guo, Xiangguo Wang, Junjin Zhao, Yuping Gao, Hemin Ni. Dihydrotestosterone through blockade of TGF-β/Smad signaling mediates the anti-fibrosis effect under hypoxia in canine Sertoli cells. The Journal of Steroid Biochemistry and Molecular Biology 2022; 216: 106041 doi: 10.1016/j.jsbmb.2021.106041
|
| 25 |
Ka‐Hei Lam, Stephanie Ma. Noncellular components in the liver cancer stem cell niche: Biology and potential clinical implications. Hepatology 2023; 78(3): 991 doi: 10.1002/hep.32629
|
| 26 |
Xian Zhong, Haiyi Long, Lili Chen, Yuhua Xie, Yifan Shi, Jianyun Peng, Ruiying Zheng, Liya Su, Yu Duan, Xiaoyan Xie, Manxia Lin. Stiffness on shear wave elastography as a potential microenvironment biomarker for predicting tumor recurrence in HBV-related hepatocellular carcinoma. Insights into Imaging 2023; 14(1) doi: 10.1186/s13244-023-01505-7
|
| 27 |
Antonella Argentiero, Antonella Delvecchio, Rossella Fasano, Alessandro Andriano, Ingrid Catalina Caradonna, Riccardo Memeo, Vanessa Desantis. The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments. Journal of Clinical Medicine 2023; 12(23): 7469 doi: 10.3390/jcm12237469
|
| 28 |
Srinivas Pittala, Yakov Krelin, Varda Shoshan-Barmatz. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide. Neoplasia 2018; 20(6): 594 doi: 10.1016/j.neo.2018.02.012
|
| 29 |
Fuat Bicer, Catrina Kure, Anil A. Ozluk, Bassel F. El-Rayes, Mehmet Akce. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC). Current Oncology 2023; 30(11): 9789 doi: 10.3390/curroncol30110711
|
| 30 |
Qingyu Cui, Bixiao Wang, Kaifu Li, Haichen Sun, Tao Hai, Yan Zhang, Hua Kang. Upregulating MMP‑1 in carcinoma‑associated fibroblasts reduces the efficacy of Taxotere on breast cancer synergized by Collagen IV. Oncology Letters 2018; doi: 10.3892/ol.2018.9092
|
| 31 |
Zeli Yin, Chengyong Dong, Keqiu Jiang, Zhe Xu, Rui Li, Kun Guo, Shujuan Shao, Liming Wang. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0782-x
|
| 32 |
Bita Mahdavi Firouzabadi, Maria Rosa Gigliobianco, Joice Maria Joseph, Roberta Censi, Piera Di Martino. Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties. Pharmaceutics 2022; 14(12): 2708 doi: 10.3390/pharmaceutics14122708
|
| 33 |
Jianfei Tu, Xihui Ying, Dengke Zhang, Qiaoyou Weng, Weibo Mao, Li Chen, Xulu Wu, Chaoyong Tu, Jiansong Ji, Yuan Huang. High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma. Oncotarget 2017; 8(67): 111623 doi: 10.18632/oncotarget.22880
|
| 34 |
Xiang Zhang, Qingqing Xiao, Cong Zhang, Qinghua Zhou, Tao Xu. Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma. Journal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18262
|
| 35 |
|
| 36 |
Emil Novruzov, Yuriko Mori, Fuad Novruzov. The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma. PET Clinics 2023; 18(3): 309 doi: 10.1016/j.cpet.2023.02.011
|
| 37 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick, Ramesh Arasaradnam. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics 2020; 10(5): 338 doi: 10.3390/diagnostics10050338
|
| 38 |
Asmaa F. Khafaga, Shaker A. Mousa, Lotfi Aleya, Mohamed M. Abdel-Daim. Three-dimensional (3D) cell culture: a valuable step in advancing treatments for human hepatocellular carcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02662-3
|
| 39 |
Weijie Deng, Peng Zhu, Huixuan Xu, Xianliang Hou, Wenbiao Chen, Zhiqian Zhang. Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2014625
|
| 40 |
Norihiro Ishii, Kenichiro Araki, Takehiko Yokobori, Kei Hagiwara, Dorgormaa Gantumur, Takahiro Yamanaka, Tadashi Handa, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Atsushi Masamune, Kazuo Umezawa, Hiroyuki Kuwano, Ken Shirabe. Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts. Cancer Science 2019; 110(1): 334 doi: 10.1111/cas.13847
|
| 41 |
Siqi Chen, Yaqing Du, Xin-Yuan Guan, Qian Yan. The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204513
|
| 42 |
Sanghwa Kim, Su-Yeon Lee, Haeng Ran Seo. Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models. BMB Reports 2023; 56(4): 225 doi: 10.5483/BMBRep.2023-0010
|
| 43 |
Devis Pascut, Muhammad Yogi Pratama, Niem V.T. Vo, Rina Masadah, Claudio Tiribelli. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications. Cancers 2020; 12(4): 823 doi: 10.3390/cancers12040823
|
| 44 |
Lotte D. de Hosson, Tim J. Takkenkamp, Gursah Kats-Ugurlu, Grietje Bouma, Marian Bulthuis, Elisabeth G. E. de Vries, Martijn van Faassen, Ido P. Kema, Annemiek M. E. Walenkamp. Neuroendocrine tumours and their microenvironment. Cancer Immunology, Immunotherapy 2020; 69(8): 1449 doi: 10.1007/s00262-020-02556-1
|
| 45 |
Takahiro Kubo, Norihisa Nishimura, Kosuke Kaji, Fumimasa Tomooka, Akihiko Shibamoto, Satoshi Iwai, Junya Suzuki, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment. International Journal of Molecular Sciences 2024; 25(8): 4405 doi: 10.3390/ijms25084405
|
| 46 |
Nilu Dhungel, Reneau Youngblood, Min Chu, Jennifer Carroll, Ana-Maria Dragoi. Assessing the epithelial-to-mesenchymal plasticity in a small cell lung carcinoma (SCLC) and lung fibroblasts co-culture model. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1096326
|
| 47 |
Bin Huang, Manping Huang, Qin Li. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway. Technology in Cancer Research & Treatment 2019; 18: 153303381987990 doi: 10.1177/1533033819879905
|
| 48 |
Natasha Zulaziz, San Jiun Chai, Kue Peng Lim. The origins, roles and therapies of cancer associated fibroblast in liver cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1151373
|
| 49 |
Jelena Radić, Bojana Kožik, Ivan Nikolić, Ivana Kolarov-Bjelobrk, Tijana Vasiljević, Bojana Vranjković, Sanja Despotović. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting. International Journal of Molecular Sciences 2023; 24(14): 11745 doi: 10.3390/ijms241411745
|
| 50 |
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
|
| 51 |
Madelyn Miller, Shadab A. Siddiqi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 377 doi: 10.1016/B978-0-323-99283-1.00008-2
|
| 52 |
Changbiao Li, Xiao Xu. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma. Cellular and Molecular Life Sciences 2019; 76(21): 4203 doi: 10.1007/s00018-019-03215-0
|
| 53 |
Baowei Lv, Wenyan Zhu, Chunqing Feng. Coptisine Blocks Secretion of Exosomal circCCT3 from Cancer-Associated Fibroblasts to Reprogram Glucose Metabolism in Hepatocellular Carcinoma. DNA and Cell Biology 2020; 39(12): 2281 doi: 10.1089/dna.2020.6058
|
| 54 |
Jiaqian Han, Xiaobo Xu, Zi Liu, Zengqiang Li, Yingliang Wu, Daiying Zuo. Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma. International Immunopharmacology 2020; 88: 106971 doi: 10.1016/j.intimp.2020.106971
|
| 55 |
Francesco Dituri, Matteo Centonze, Erwin J. W. Berenschot, Niels R. Tas, Arturo Susarrey-Arce, Silke Krol. Complex Tumor Spheroid Formation and One-Step Cancer-Associated Fibroblasts Purification from Hepatocellular Carcinoma Tissue Promoted by Inorganic Surface Topography. Nanomaterials 2021; 11(12): 3233 doi: 10.3390/nano11123233
|
| 56 |
Junki Maehara, Yohei Masugi, Tokiya Abe, Hanako Tsujikawa, Yutaka Kurebayashi, Akihisa Ueno, Hidenori Ojima, Shigeo Okuda, Masahiro Jinzaki, Masahiro Shinoda, Yuko Kitagawa, Yoshinao Oda, Hiroshi Honda, Michiie Sakamoto. Quantification of intratumoral collagen and elastin fibers within hepatocellular carcinoma tissues finds correlations with clinico‐patho‐radiological features. Hepatology Research 2020; 50(5): 607 doi: 10.1111/hepr.13484
|
| 57 |
Vito Longo, Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Sabina Delcuratolo, Riccardo Memeo, Antonio Giovanni Solimando, Antonella Argentiero. Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Medicina 2019; 55(10): 698 doi: 10.3390/medicina55100698
|
| 58 |
Xiaocheng Zhou, Tinglin Yan, Chunming Huang, Zhi Xu, Lin Wang, Erhui Jiang, Hui Wang, Yang Chen, Ke Liu, Zhe Shao, Zhengjun Shang. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0911-3
|
| 59 |
Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, Gianluigi Ferretti, Francesco Cognetti, Ludovica Ciuffreda, Michele Milella. Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy. Cancers 2020; 12(10): 2870 doi: 10.3390/cancers12102870
|
| 60 |
Nesil Yalman. LMCD1 antisense RNA 1 is a newly identified long noncoding RNA. Anti-Cancer Drugs 2022; 33(1): 1 doi: 10.1097/CAD.0000000000001124
|
| 61 |
Yanying Li, Jingliang Wu, Qiao Lu, Xuemin Liu, Jiaxuan Wen, Xiaohui Qi, Jianhao Liu, Bo Lian, Bo Zhang, Hengyi Sun, Guixiang Tian. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma. International Journal of Nanomedicine 2022; : 2559 doi: 10.2147/IJN.S366180
|
| 62 |
Yuanzhen Sun, Xiaoli Fan, Qing Zhang, Xiaoyu Shi, Guangwei Xu, Cuimin Zou. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling. Tumor Biology 2017; 39(7): 101042831771259 doi: 10.1177/1010428317712592
|
| 63 |
Yun-Hong Xia, Zhen Lu, Min Zhao, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Guo-Lin Jiang. Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells. Oncotarget 2017; 8(33): 55084 doi: 10.18632/oncotarget.19027
|
| 64 |
Shuo Wang, Peng Du, Yudong Cao, Jinchao Ma, Xiao Yang, Ziyi Yu, Yong Yang. Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01163-6
|
| 65 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
| 66 |
Qiong Wang, Yu‐Chao Zhang, Li‐Fang Zhu, Lu Pan, Miao Yu, Wei‐Li Shen, Bang Li, Wei Zhang, Lai‐Kui Liu. Heat shock factor 1 in cancer‐associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma. Cancer Science 2019; 110(5): 1790 doi: 10.1111/cas.13991
|
| 67 |
Jianming Hu, Leyi Zhang, Wuzhen Chen, Lesang Shen, Jingxin Jiang, Shanshan Sun, Zhigang Chen. Role of Intra- and Extracellular Lipid Signals in Cancer Stemness and Potential Therapeutic Strategy. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.730751
|
| 68 |
Anh Tuan Nguyen, Joanne Chia, Manon Ros, Kam Man Hui, Frederic Saltel, Frederic Bard. Organelle Specific O-Glycosylation Drives MMP14 Activation, Tumor Growth, and Metastasis. Cancer Cell 2017; 32(5): 639 doi: 10.1016/j.ccell.2017.10.001
|
| 69 |
Lawrence M Agius. Dimensions of Niche-Induced Anti-Apoptosis of Therapeutically Resistant Neoplasms in Radio-Chemo-Therapy. International Journal of Radiology & Radiation Therapy 2017; 2(3) doi: 10.15406/ijrrt.2017.02.00026
|
| 70 |
Massimiliano Cadamuro, Giorgia Nuozzi, Paolo Simioni, Luca Fabris. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.94
|
| 71 |
Jeannette Huaman, Cuong Bach, Adeodat Ilboudo, Olorunseun O. Ogunwobi. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 131 doi: 10.1007/978-3-319-68082-8_8
|
| 72 |
Wenge Dong, Yangyang Xie, Hai Huang. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.884777
|
| 73 |
Yongfang Wang, Hanyun Liang, Jie Zheng. Exosomal microRNAs mediating crosstalk between cancer cells and cancer-associated fibroblasts in the tumor microenvironment. Pathology - Research and Practice 2022; 239: 154159 doi: 10.1016/j.prp.2022.154159
|
| 74 |
Ning Zhang, Long-Rong Wang, Dou-Dou Li, De-Ning Ma, Cheng-Hao Wang, Xi-Gan He, Dong-Mei Gao, Lu Wang, Zhao-You Tang. Interferon-α Combined With Herbal Compound “Songyou Yin” Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model. Integrative Cancer Therapies 2018; 17(4): 1260 doi: 10.1177/1534735418801525
|
| 75 |
Fugen Takagi, Motomasa Furuse, Hiroko Kuwabara, Akihiro Kambara, Naoki Omura, Shogo Tanabe, Ryokichi Yagi, Ryo Hiramatsu, Masahiro Kameda, Naosuke Nonoguchi, Shinji Kawabata, Toshihiro Takami, Shin‐Ichi Miyatake, Masahiko Wanibuchi. Expression and distribution of hypoxia‐inducible factor‐1α and vascular endothelial growth factor in comparison between radiation necrosis and tumor tissue in metastatic brain tumor: A case report. Neuropathology 2023; doi: 10.1111/neup.12958
|
| 76 |
Chun-Feng Xie, Kun-Liang Feng, Ji-Nan Wang, Rui Luo, Chong-Kai Fang, Ying Zhang, Chuang-Peng Shen, Chong Zhong. Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling. Journal of Ethnopharmacology 2022; 294: 115360 doi: 10.1016/j.jep.2022.115360
|
| 77 |
Jie Zhang, Chaoyu Gu, Qianqian Song, Mengqi Zhu, Yuqing Xu, Mingbing Xiao, Wenjie Zheng. Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00488-y
|
| 78 |
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(17): 4387 doi: 10.3390/cancers13174387
|
| 79 |
Wei Li, Qiang Fu, Wenling Man, Huanqing Guo, Po Yang. LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1/akt/mTOR pathway. European Journal of Pharmacology 2019; 849: 106 doi: 10.1016/j.ejphar.2019.01.049
|
| 80 |
Avijit Paul, Yakov Krelin, Tasleem Arif, Rina Jeger, Varda Shoshan-Barmatz. A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis. Molecular Therapy 2018; 26(3): 680 doi: 10.1016/j.ymthe.2017.12.020
|
| 81 |
Yuting Gao, Yi Gong, Junlan Lu, Huiqin Hao, Xinli Shi. Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1377722
|
| 82 |
Jie Zhao, Shaobo Yang, Caihong Lv, Ying Liu. Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1. American Journal of Physiology-Cell Physiology 2023; 324(5): C1039 doi: 10.1152/ajpcell.00454.2022
|
| 83 |
Qing Li, Chun-Chao Zhu, Bo Ni, Zi-Zhen Zhang, Shu-Heng Jiang, Li-Peng Hu, Xu Wang, Xiao-Xin Zhang, Pei-Qi Huang, Qin Yang, Jun Li, Jian-Ren Gu, Jia Xu, Kathy Qian Luo, Gang Zhao, Zhi-Gang Zhang. Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts. eBioMedicine 2019; 49: 157 doi: 10.1016/j.ebiom.2019.10.037
|
| 84 |
Hiroyuki Kuwano, Takehiko Yokobori, Tatsuya Miyazaki, Makoto Sohda, Tomonori Yoshida, Yoko Azuma, Hironori Tatsuki, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Hiroshi Saeki, Ken Shirabe. Field carcinogenesis and biological significance of the potential of the bystander effect: carcinogenesis, therapeutic response, and tissue regeneration. Surgery Today 2023; 53(5): 545 doi: 10.1007/s00595-022-02524-5
|
| 85 |
Hao Wang, Wenwei Zhu, Shuhua Ren, Yanyan Kong, Qi Huang, Jun Zhao, Yihui Guan, Huliang Jia, Jinhong Chen, Lu Lu, Fang Xie, Lunxiu Qin. 68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.693640
|
| 86 |
Thuc Ly, Gunjan Gaur, Sufi Mary Thomas. Autophagy and Metabolism. 2022; : 163 doi: 10.1016/B978-0-323-99879-6.00004-3
|
| 87 |
Xian Zhong, Lili Chen, Haiyi Long, Ruiying Zheng, Liya Su, Yu Duan, Xiaoyan Xie, Manxia Lin. The “stiff rim” sign of hepatocellular carcinoma on shear wave elastography: correlation with pathological features and potential prognostic value. Abdominal Radiology 2022; 47(12): 4115 doi: 10.1007/s00261-022-03628-9
|
| 88 |
Francesco Dituri, Serena Mancarella, Grazia Serino, Nada Chaoul, Luigi Giovanni Lupo, Erica Villa, Isabel Fabregat, Gianluigi Giannelli. Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment. International Journal of Molecular Sciences 2021; 22(21): 11765 doi: 10.3390/ijms222111765
|
| 89 |
Jung Woo Eun, Jung Hwan Yoon, Hye Ri Ahn, Seokhwi Kim, Young Bae Kim, Su Bin Lim, Won Park, Tae Wook Kang, Geum Ok Baek, Moon Gyeong Yoon, Ju A Son, Ji Hyang Weon, Soon Sun Kim, Hyo Jung Cho, Jae Youn Cheong. Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Communications 2023; 43(4): 455 doi: 10.1002/cac2.12414
|
| 90 |
Jacek R Wilczyński, Miłosz Wilczyński, Edyta Paradowska. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies. International Journal of Molecular Sciences 2022; 23(5): 2496 doi: 10.3390/ijms23052496
|
| 91 |
Samantha M. Ruff, Timothy M. Pawlik. Emerging therapies targeting growth factors in hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2024; 25(3): 255 doi: 10.1080/14656566.2024.2340714
|
| 92 |
Yunbin Zhang, Jiang Xu, Ning Zhang, Ming Chen, Hua Wang, Di Zhu. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Letters 2019; 458: 123 doi: 10.1016/j.canlet.2019.05.017
|
| 93 |
Man Yao, Shufang Liang, Binbin Cheng. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1110922
|
| 94 |
Radwa Ayman Salah, Mohamed A. Nasr, Azza M. El-Derby, M. Abd Elkodous, Rania Hassan Mohamed, Nada El-Ekiaby, Aya Osama, Shimaa E. Elshenawy, Merna Hatem Mohamed Hamad, Sameh Magdeldin, Mahmoud M. Gabr, Ahmed I. Abdelaziz, Nagwa S. El-Badri. Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells. Life Sciences 2022; 288: 120168 doi: 10.1016/j.lfs.2021.120168
|
| 95 |
James B. McCarthy, Dorraya El-Ashry, Eva A. Turley. Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression. Frontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00048
|
| 96 |
Hyungjin Rhee, Taek Chung, Jeong Eun Yoo, Ji Hae Nahm, Ha Young Woo, Gi Hong Choi, Dai Hoon Han, Young Nyun Park. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression. Hepatology International 2020; 14(2): 239 doi: 10.1007/s12072-020-10012-6
|
| 97 |
Xiaobo Zheng, Peng Wang, Li Li, Jing Yu, Chune Yu, Liangliang Xu, Lian Li, Fuzhen Dai, Lei Feng, Hong Zou, Xiaobo Chen, Ming Zhang, Mingqing Xu. Cancer-Associated Fibroblasts Promote Vascular Invasion of Hepatocellular Carcinoma via Downregulating Decorin-integrin β1 Signaling. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.678670
|
| 98 |
Shaoping She, Liying Ren, Pu Chen, Mingyang Wang, Dongbo Chen, Ying Wang, Hongsong Chen. Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.812431
|
| 99 |
Amanda J. Craig, Johann von Felden, Teresa Garcia-Lezana, Samantha Sarcognato, Augusto Villanueva. Tumour evolution in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2020; 17(3): 139 doi: 10.1038/s41575-019-0229-4
|
| 100 |
Wei Jing, Ruoyu Peng, Xiaogai Li, Shaogang Lv, Yu Duan, Shitao Jiang, Fu Wang. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/7267131
|
| 101 |
Wenqi Shen, Ping-an Yao, Wenjing Li, Changji Gu, Tian Gao, Yi Cao, Zheng Wang, Renjun Pei, Chungen Xing. Cancer-associated fibroblast-targeted nanodrugs reshape colorectal tumor microenvironments to suppress tumor proliferation, metastasis and improve drug penetration. Journal of Materials Chemistry B 2023; 11(9): 1871 doi: 10.1039/D2TB02253B
|
| 102 |
Yang Liu, Xi Zhang, Junjun Zhang, Juan Tan, Jie Li, Zewen Song. Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.596679
|
| 103 |
Alba Herrero, Elisabeth Knetemann, Inge Mannaerts. Review: Challenges of In Vitro CAF Modelling in Liver Cancers. Cancers 2021; 13(23): 5914 doi: 10.3390/cancers13235914
|
| 104 |
Chao Li, Adilson Fonseca Teixeira, Hong-Jian Zhu, Peter ten Dijke. Cancer associated-fibroblast-derived exosomes in cancer progression. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01463-y
|
| 105 |
Paul J. Wrighton, Isaac M. Oderberg, Wolfram Goessling. There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology 2019; 8(3): 347 doi: 10.1016/j.jcmgh.2019.05.002
|
| 106 |
Yuanfei Lu, Na Feng, Yongzhong Du, Risheng Yu. Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma. Nanomaterials 2022; 12(16): 2832 doi: 10.3390/nano12162832
|
| 107 |
Austin Cook, Shadab A. Siddiqi. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 303 doi: 10.1007/978-3-030-48405-7_14
|
| 108 |
Takahiro Yamanaka, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Tadashi Handa, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Kenichiro Araki, Kazuo Umezawa, Ken Shirabe. Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein–coupled Receptor 68. Molecular Cancer Therapeutics 2021; 20(6): 1019 doi: 10.1158/1535-7163.MCT-20-0150
|
| 109 |
Xiang Li, Erhui Jiang, Hui Zhao, Yang Chen, Yuming Xu, Chunyu Feng, Ji Li, Zhengjun Shang. Glycometabolic reprogramming-mediated proangiogenic phenotype enhancement of cancer-associated fibroblasts in oral squamous cell carcinoma: role of PGC-1α/PFKFB3 axis. British Journal of Cancer 2022; 127(3): 449 doi: 10.1038/s41416-022-01818-2
|
| 110 |
Guixiong Zhang, Yitai Xiao, Xiaokai Zhang, Wenzhe Fan, Yue Zhao, Yanqin Wu, Hongyu Wang, Jiaping Li. Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.978050
|
| 111 |
Nyanbol Kuol, Lily Stojanovska, Kulmira Nurgali, Vasso Apostolopoulos. The mechanisms tumor cells utilize to evade the host's immune system. Maturitas 2017; 105: 8 doi: 10.1016/j.maturitas.2017.04.014
|
| 112 |
Margaux Sala, Manon Ros, Frédéric Saltel. A Complex and Evolutive Character: Two Face Aspects of ECM in Tumor Progression. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01620
|
| 113 |
Shika Hanif Malgundkar, Yahya Tamimi. Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer. Future Science OA 2023; 9(1) doi: 10.2144/fsoa-2022-0032
|
| 114 |
Zeli Yin, Keqiu Jiang, Rui Li, Chengyong Dong, Liming Wang. Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0926-6
|
| 115 |
Atsunori Tsuchiya, Masahiro Ogawa, Takayuki Watanabe, Suguru Takeuchi, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma. Heliyon 2019; 5(3): e01325 doi: 10.1016/j.heliyon.2019.e01325
|
| 116 |
Yuan Zhou, Haozhen Ren, Bo Dai, Jun Li, Longcheng Shang, Jianfei Huang, Xiaolei Shi. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0965-2
|
| 117 |
Irmak Ayvaz, Dilara Sunay, Ece Sariyar, Esra Erdal, Zeynep Firtina Karagonlar. Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma — a Review. Journal of Gastrointestinal Cancer 2021; 52(4): 1294 doi: 10.1007/s12029-021-00772-1
|
| 118 |
Meng Zhang, Junlong Zhu, Pan Zhang, Lingxun Li, Min Min, Tinghao Li, Weiyang He. Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1174252
|
| 119 |
Hongjin Wang, Nian Wang, Ze Tang, Qiuyu Liu, Shiyu Nie, Wu Tao. An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis. Hereditas 2023; 160(1) doi: 10.1186/s41065-023-00288-7
|
| 120 |
Zhen Lu, Yun-Hong Xia, Min Zhao, Bing Zhang, Wen-Ting Dai, Lu Ding, Li-Xia Hu, Jin-Ling Bi, Guo-Lin Jiang. DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth. Oncotarget 2017; 8(33): 54993 doi: 10.18632/oncotarget.18990
|
| 121 |
Dashuai Yang, Yang Su, Fangrui Zhao, Chen Chen, Kailiang Zhao, Xiangyun Xiong, Youming Ding. A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.920589
|
| 122 |
Srija Chakraborty, Thomas J. DePalma, Aleksander Skardal. Increasing Accuracy of In Vitro Cancer Models: Engineering Stromal Complexity into Tumor Organoid Platforms. Advanced NanoBiomed Research 2021; 1(12) doi: 10.1002/anbr.202100061
|
| 123 |
Iftikhar Ali Khawar, Jong Kook Park, Eun Sun Jung, Myung Ah Lee, Suhwan Chang, Hyo-Jeong Kuh. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma. Neoplasia 2018; 20(8): 800 doi: 10.1016/j.neo.2018.05.008
|
| 124 |
Kevin Dzobo, Collet Dandara. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes. OMICS: A Journal of Integrative Biology 2020; 24(6): 340 doi: 10.1089/omi.2020.0042
|
| 125 |
Muyue Yang, Jipeng Li, Ping Gu, Xianqun Fan. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioactive Materials 2021; 6(7): 1973 doi: 10.1016/j.bioactmat.2020.12.010
|